Results 141 to 150 of about 43,522 (228)

Computational Study of Coumarin Compounds as Potential Inhibitors of Casein Kinase 2: DFT, 2D-QSAR, ADMET and Molecular Docking Investigations

open access: yes
Casein kinase 2 (CK2) is an ubiquitous, essential, and highly pleiotropic protein kinase whose abnormally high constitutive activity is suspected to underlie its pathogenic potential in neoplasia and other diseases.
Belaidi, Salah   +6 more
core   +1 more source

Polycation-dependent, Ca2+-antagonized phosphorylation of calmodulin by casein kinase-2 and a spleen tyrosine protein kinase.

open access: yes, 1987
Ten distinct protein kinases have been tested for their ability to phosphorylate calmodulin. Only casein kinase-2 and a spleen tyrosine protein kinase (TPK-III) proved effective, their phosphorylation efficiency being dramatically enhanced by histones ...
PINNA, LORENZO   +6 more
core   +1 more source

Quaternary Structure of Casein Kinase 2 [PDF]

open access: yesJournal of Biological Chemistry, 1995
Emmanuelle Valero   +6 more
openaire   +1 more source

Data from: Prion protein inhibits fast axonal transport through a mechanism involving casein kinase 2

open access: yes, 2017
Prion diseases include a number of progressive neuropathies involving conformational changes in cellular prion protein (PrPc) that may be fatal sporadic, familial or infectious.
Song, Yuyu   +14 more
core   +1 more source

Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human alpha-synuclein: Implication for alpha-synucleinopathies.

open access: yes, 2007
In Lewy body diseases and multiple system atrophy, alpha-synuclein is hyperphosphorylated at Ser129, suggesting a role in pathogenesis. Here, we report purification of the protein kinase in rat brain that phosphorylates Ser129 and its identification as ...
Arai, T   +9 more
core   +1 more source

Disruption in the regulation of casein kinase 2 in circadian rhythm leads to pathological states: cancer, diabetes and neurodegenerative disorders. [PDF]

open access: yesFront Mol Neurosci, 2023
Malik MZ   +7 more
europepmc   +1 more source

Exploring the potential of approved drugs for triple-negative breast cancer treatment by targeting casein kinase 2: Insights from computational studies. [PDF]

open access: yesPLoS One, 2023
Shoaib TH   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy